<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Female infertility: Causes</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Female infertility: Causes</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Female infertility: Causes</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wendy Kuohung, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark D Hornstein, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert L Barbieri, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 07, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Infertility is a complex disorder with significant medical, psychosocial, and economic aspects. The etiologies of female infertility will be reviewed here. Evaluation and treatment of female infertility are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5445.html" rel="external">"Female infertility: Evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/5448.html" rel="external">"Female infertility: Treatments"</a>.)</p><p>Causes of male infertility are also discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7473.html" rel="external">"Causes of male infertility"</a>.)</p><p>In this topic, when discussing study results, we will use the terms "woman/en" or "patient(s)" as they are used in the studies presented. However, we encourage the reader to consider the specific counseling and treatment needs of transgender and gender expansive individuals.</p><p class="headingAnchor" id="H2"><span class="h1">OVERVIEW</span><span class="headingEndMark"> — </span>In a World Health Organization (WHO) study of 8500 infertile couples, female factor infertility was reported in 37 percent of infertile couples in developed countries, male factor infertility in 8 percent, and both male and female factor infertility in 35 percent [<a href="#rid1">1</a>]. The remaining couples had unexplained infertility or became pregnant during the study. The most common identifiable female factors, which accounted for 81 percent of female infertility, were:</p><p class="bulletIndent1"><span class="glyph">●</span>Ovulatory disorders (25 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Endometriosis (15 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Pelvic adhesions (12 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Tubal blockage (11 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Other tubal abnormalities (11 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Hyperprolactinemia (7 percent)</p><p></p><p>With advancing female age, there is an increase in the percentage of women with age-related infertility. In addition, other factors that may reduce fertility, such as leiomyomas, tubal disease, and endometriosis, also increase. A reduction in coital frequency with increasing age also impacts fertility [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H18439130"><span class="h1">OVARY</span></p><p class="headingAnchor" id="H3"><span class="h2">Ovulatory disorders</span><span class="headingEndMark"> — </span>Infrequent ovulation (oligoovulation) or absent ovulation (anovulation) results in infertility because an oocyte is not available every month for fertilization. Women who report monthly menses and molimina (breast tenderness, dysmenorrhea, bloating) are typically ovulatory. If menses and molimina are irregular or absent, pregnancy or another condition associated with oligoovulation/anovulation is likely. Potential causes are listed in the table  (<a class="graphic graphic_table graphicRef79628" href="/z/d/graphic/79628.html" rel="external">table 1</a>) (see individual topic reviews for more information on each disorder).</p><p>The World Health Organization has classified anovulation into three main groups, and recognizes hyperprolactinemia as additional etiology  (<a class="graphic graphic_table graphicRef69734" href="/z/d/graphic/69734.html" rel="external">table 2</a>). This system is useful for defining and treating anovulatory disorders according to the underlying endocrine dysfunction.</p><p class="headingAnchor" id="H4"><span class="h2">Oocyte aging</span><span class="headingEndMark"> — </span>Age is an important factor affecting a woman's fertility  (<a class="graphic graphic_figure graphicRef50854" href="/z/d/graphic/50854.html" rel="external">figure 1</a>). The decrease in fecundability with aging is likely due to a decline in both the quantity and quality of the oocytes.</p><p>The germ cell complement of the ovary reaches its apex of 6 to 7 million follicles in the mid-gestation female fetus, followed by a steady attrition from 1 to 2 million follicles at birth to 300,000 follicles at the onset of puberty [<a href="#rid3">3</a>]. The rate of follicle loss accelerates after the woman reaches her mid-thirties [<a href="#rid4">4,5</a>] (see  <a class="medical medical_review" href="/z/d/html/421.html" rel="external">"Effects of advanced maternal age on pregnancy"</a>). Other insults to the ovary such as cigarette smoking, radiation, chemotherapy, and autoimmune disease also accelerate follicular loss [<a href="#rid6">6-8</a>]. Women with a depleted ovarian follicle pool may continue to ovulate regularly, but have infertility due to the poor quality of oocytes remaining in the terminal follicular pool. (See  <a class="medical medical_review" href="/z/d/html/7435.html" rel="external">"Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)"</a>.)</p><p>The loss of oocyte quality as a woman ages is thought to be due to an increase in meiotic nondisjunction. Hypothesized mechanisms involve differences between germ cells when formed during fetal life, damage in germ cells that accumulates over the course of a woman’s life, or age-related changes in the quality of the granulosa cells surrounding the oocyte [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H81102118"><span class="h2">Ovarian cysts</span><span class="headingEndMark"> — </span>A review of epidemiologic data, drawn mainly from comparative studies and cohorts, concluded that it is unclear whether small (&lt;3 to 6 cm) ovarian cysts have a role in infertility and that the effects of surgical treatment are often more harmful than the cyst itself to the ovarian reserve [<a href="#rid10">10</a>]. Most of these data involved endometriomas. (See  <a class="medical medical_review" href="/z/d/html/3282.html" rel="external">"Endometriosis: Management of ovarian endometriomas", section on 'Assess fertility and desire for pregnancy'</a>.)</p><p class="headingAnchor" id="H5"><span class="h1">FALLOPIAN TUBE ABNORMALITIES/PELVIC ADHESIONS</span><span class="headingEndMark"> — </span>Tubal disease and pelvic adhesions prevent normal transport of the oocyte and sperm through the fallopian tube. The primary cause of tubal factor infertility is pelvic inflammatory disease caused by pathogens such as chlamydial or gonorrhea. Other conditions that may interfere with tubal transport include severe endometriosis (see <a class="local">'Endometriosis'</a> below), adhesions from previous surgery or nontubal infection (eg, appendicitis, inflammatory bowel disease), pelvic tuberculosis, and salpingitis isthmica nodosa (ie, diverticulosis of the fallopian tube). Proximal tubal blockage may result from plugs of mucus and amorphous debris or spasm of the uterotubal ostium, but does not reflect true anatomic occlusion [<a href="#rid11">11</a>]. (See  <a class="medical medical_review" href="/z/d/html/7585.html" rel="external">"Pelvic inflammatory disease: Treatment in adults and adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/7408.html" rel="external">"Endometriosis: Treatment of infertility in females"</a>.)</p><p>Women with distal tubal obstruction may develop hydrosalpinges, which decrease the success rate of in vitro fertilization (IVF). In addition to obstruction to sperm migration, hydrosalpinges appear to reduce fertility by retrograde flow of tubal contents into the endometrial cavity, which creates a hostile environment to implantation of an embryo. Removal of the hydrosalpinges increases the success of IVF. (See  <a class="medical medical_review" href="/z/d/html/3279.html" rel="external">"Female infertility: Reproductive surgery", section on 'Salpingectomy before in vitro fertilization'</a>.)</p><p class="headingAnchor" id="H18439152"><span class="h1">UTERUS</span><span class="headingEndMark"> — </span>Impaired implantation, either mechanical or due to reduced endometrial receptivity, are the basis of uterine causes of infertility.</p><p class="headingAnchor" id="H6"><span class="h2">Uterine fibroids (leiomyomata)</span><span class="headingEndMark"> — </span>Uterine fibroids are common benign smooth muscle monoclonal tumors. Although conflicting data exist, it appears that fibroids with a submucosal or intracavitary component can lower pregnancy and implantation rates, as shown by improved pregnancy rates following removal of such lesions, although supporting data conflict [<a href="#rid12">12,13</a>]. However, the impact of fibroid presence or removal on live birth rate is unclear. The impact of fibroids on fertility and treatment in individuals who desire pregnancy is discussed in related content.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5486.html" rel="external">"Uterine fibroids (leiomyomas): Epidemiology, clinical features, diagnosis, and natural history", section on 'Infertility or obstetric complications'</a>.)</p><p></p><p class="headingAnchor" id="H7"><span class="h2">Uterine anomalies</span><span class="headingEndMark"> — </span>Uterine abnormalities are thought to cause infertility by interfering with normal implantation. Müllerian anomalies are a significant cause of recurrent pregnancy loss (RPL), with the septate uterus associated with the poorest reproductive outcome [<a href="#rid14">14</a>]. Other structural abnormalities associated with infertility include endometrial polyps, and synechiae from prior pregnancy-related curettage. However, data establishing a causal link between these uterine abnormalities and infertility are lacking. (See  <a class="medical medical_review" href="/z/d/html/5418.html" rel="external">"Congenital uterine anomalies: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5457.html" rel="external">"Endometrial polyps"</a> and  <a class="medical medical_review" href="/z/d/html/3285.html" rel="external">"Intrauterine adhesions: Clinical manifestation and diagnosis"</a>.)</p><p class="headingAnchor" id="H873042206"><span class="h2">Intrauterine adhesions</span><span class="headingEndMark"> — </span>Intrauterine adhesions as a cause of infertility are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/3285.html" rel="external">"Intrauterine adhesions: Clinical manifestation and diagnosis", section on 'Clinical presentation'</a>.)</p><p class="headingAnchor" id="H18439229"><span class="h2">Luteal phase defect</span><span class="headingEndMark"> — </span>Luteal phase defect (LPD) refers to abnormalities of the corpus luteum that result in inadequate production of progesterone, which is necessary for making the endometrium receptive to implantation. A 2015 committee opinion from the American Society of Reproductive Medicine concluded that "although progesterone is important for the process of implantation and early embryonic development, luteal phase defect (LPD) as an independent entity causing infertility has not been proven" [<a href="#rid15">15</a>]. There are no agreed upon definitions, diagnostic tests, or treatments for LPD [<a href="#rid15">15</a>]. We agree that endometrial dating is not useful for evaluating or guiding treatment of infertile women [<a href="#rid16">16,17</a>].</p><p class="headingAnchor" id="H8"><span class="h1">ENDOMETRIOSIS</span><span class="headingEndMark"> — </span>Mechanisms which decrease fertility in women with endometriosis include anatomic distortion from pelvic adhesions, damage to ovarian tissue by endometrioma formation and surgical resection, and the production of substances such as cytokines and growth factors which impair the normal processes of ovulation, fertilization, and implantation. (See  <a class="medical medical_review" href="/z/d/html/7408.html" rel="external">"Endometriosis: Treatment of infertility in females"</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">CERVICAL FACTORS</span><span class="headingEndMark"> — </span>Normal midcycle cervical mucus facilitates the transport of sperm. Congenital malformations and trauma to the cervix (including surgery) may result in stenosis and inability of the cervix to produce normal mucus, thereby impairing fertility. (See  <a class="medical medical_review" href="/z/d/html/5428.html" rel="external">"Benign cervical lesions and congenital anomalies of the cervix"</a>.)</p><p class="headingAnchor" id="H196627344"><span class="h1">INHERITED THROMBOPHILIA</span><span class="headingEndMark"> — </span>Inherited thrombophilias do not appear to be related to unexplained infertility [<a href="#rid18">18,19</a>]. A large retrospective study reported no significant association with common thrombophilias, including factor V Leiden and lupus anticoagulant, and diminished in vitro fertilization success [<a href="#rid20">20</a>]. Thus, neither screening for thrombophilias nor treating them is advised in cases of repeated infertility treatment failure.</p><p class="headingAnchor" id="H15951438"><span class="h1">IMMUNE FACTORS</span></p><p class="headingAnchor" id="H1916908512"><span class="h2">Autoantibodies</span><span class="headingEndMark"> — </span>An increased frequency of abnormal immune test results in women with early reproductive failure has been reported repeatedly; however, the most rigorous studies have not proven a cause and effect between these phenomena [<a href="#rid21">21</a>]. Immune testing of infertile couples in clinical practice is not supported by existing data, and treatments administered to address abnormal results on immunologic testing solely for the purpose of improving fertility have not been proven to be beneficial and may cause harm.</p><p>Women with some autoimmune diseases are at increased risk of infertility unrelated to direct effects of these antibodies on fertilization and implantation. For example, premature ovarian failure has also been described in women with systemic lupus erythematosus and myasthenia gravis. Autoimmune oophoritis may occur as part of type I and type II syndromes of polyglandular autoimmune failure, which are associated with autoantibodies to multiple endocrine and other organs.</p><p class="headingAnchor" id="H432168534"><span class="h2">Celiac disease</span><span class="headingEndMark"> — </span>Women with untreated celiac disease may have an increased frequency of reproductive abnormalities, including infertility, miscarriage, and intrauterine growth restriction [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/z/d/html/4774.html" rel="external">"Epidemiology, pathogenesis, and clinical manifestations of celiac disease in adults", section on 'Menstrual and reproductive issues'</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">GENETIC CAUSES</span><span class="headingEndMark"> — </span>Infertile couples have been shown to have a higher prevalence of karyotype abnormalities (trisomies, mosaics, translocations, etc) than the general population [<a href="#rid23">23</a>]. The frequency varies according to the cause of infertility and clinical history. The most common aneuploidies associated with infertility are 45, X (Turner syndrome) in women and 47, XXY (Klinefelter syndrome) in men. (See  <a class="medical medical_review" href="/z/d/html/7391.html" rel="external">"Clinical manifestations and diagnosis of Turner syndrome"</a> and  <a class="medical medical_review" href="/z/d/html/7459.html" rel="external">"Causes of primary hypogonadism in males", section on 'Klinefelter syndrome'</a>.)</p><p>Individual genes that affect fecundity have been identified, including <em>KAL1</em> (Kallmann's syndrome) [<a href="#rid24">24</a>], GnRH receptor [<a href="#rid25">25,26</a>], FSH receptor [<a href="#rid27">27</a>], beta subunit of FSH [<a href="#rid28">28</a>], LH receptor [<a href="#rid29">29</a>], <em>FMR1</em> (fragile X messenger ribonucleoprotein 1) [<a href="#rid30">30</a>], <em>SF1</em>, <em>DAX1</em> [<a href="#rid31">31</a>], <em>LEP</em> (leptin) [<a href="#rid32">32</a>], <em>LEP</em> receptor [<a href="#rid33">33</a>], <em>GPR54</em> [<a href="#rid34">34,35</a>], <em>FGFR1</em> [<a href="#rid36">36</a>], and <em>TUBB8</em> [<a href="#rid37">37</a>]. <em>TUBB8 </em>mutations are unique in that they impact only oocytes. <em>TUBB8</em> mutations disrupt microtubule function during oocyte division and thereby arrest human oocyte maturation and prevent fertilization [<a href="#rid37">37</a>]. Of these genes, clinical testing is available for abnormalities of <em>FMR1, </em>which causes fragile X syndrome. (See  <a class="medical medical_review" href="/z/d/html/437.html" rel="external">"Fragile X syndrome: Prenatal screening and diagnosis"</a>.)</p><p class="headingAnchor" id="H13"><span class="h1">LIFESTYLE FACTORS</span><span class="headingEndMark"> — </span>Lifestyle factors which may contribute to subfertility are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/5411.html" rel="external">"Natural fertility and impact of lifestyle factors"</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">UNEXPLAINED</span><span class="headingEndMark"> — </span>Unexplained infertility is the diagnosis given to couples after a thorough evaluation has not revealed a cause. Many cases of unexplained infertility may be due to small contributions from multiple factors. (See  <a class="medical medical_review" href="/z/d/html/7410.html" rel="external">"Unexplained infertility"</a>.)</p><p class="headingAnchor" id="H349227786"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/114191.html" rel="external">"Society guideline links: Female infertility"</a>.)</p><p class="headingAnchor" id="H15"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/15424.html" rel="external">"Patient education: Female infertility (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/15426.html" rel="external">"Patient education: Infertility in couples (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/8420.html" rel="external">"Patient education: Ovulation induction with clomiphene or letrozole (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/z/d/html/2175.html" rel="external">"Patient education: Evaluation of infertility in couples (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H16"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Common causes</strong> –<strong> </strong>The most common causes of female infertility include: ovulatory dysfunction (age or non-age related), fallopian tube abnormalities (related to pelvic adhesions and infection), endometriosis, uterine abnormalities (congenital or acquired), and cervical factors. (See <a class="local">'Overview'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">WHO Technical Report Series. Recent Advances in Medically Assisted Conception Number 820, 1992, pp 1-111.</li><li><a class="nounderline abstract_t">American College of Obstetricians and Gynecologists Committee on Gynecologic Practice and Practice Committee. Female age-related fertility decline. Committee Opinion No. 589. Fertil Steril 2014; 101:633. Reaffirmed 2022.</a></li><li><a class="nounderline abstract_t">Baker TG. Radiosensitivity of mammalian oocytes with particular reference to the human female. Am J Obstet Gynecol 1971; 110:746.</a></li><li><a class="nounderline abstract_t">Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987; 65:1231.</a></li><li><a class="nounderline abstract_t">Faddy MJ, Gosden RG. A mathematical model of follicle dynamics in the human ovary. Hum Reprod 1995; 10:770.</a></li><li><a class="nounderline abstract_t">Jick H, Porter J. Relation between smoking and age of natural menopause. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet 1977; 1:1354.</a></li><li><a class="nounderline abstract_t">Cramer DW, Barbieri RL, Xu H, Reichardt JK. Determinants of basal follicle-stimulating hormone levels in premenopausal women. J Clin Endocrinol Metab 1994; 79:1105.</a></li><li><a class="nounderline abstract_t">Westhoff C, Murphy P, Heller D. Predictors of ovarian follicle number. Fertil Steril 2000; 74:624.</a></li><li><a class="nounderline abstract_t">Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev 2009; 30:465.</a></li><li><a class="nounderline abstract_t">Legendre G, Catala L, Morinière C, et al. Relationship between ovarian cysts and infertility: what surgery and when? Fertil Steril 2014; 101:608.</a></li><li><a class="nounderline abstract_t">Practice Committee of the American Society for Reproductive Medicine. Committee opinion: role of tubal surgery in the era of assisted reproductive technology. Fertil Steril 2012; 97:539.</a></li><li><a class="nounderline abstract_t">Practice Committee of the American Society for Reproductive Medicine. Electronic address: <span class="__cf_email__" data-cfemail="5c1d0f0e111c3d2f2e3172332e3b">[email protected]</span>, Practice Committee of the American Society for Reproductive Medicine. Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertil Steril 2017; 108:416.</a></li><li><a class="nounderline abstract_t">Metwally M, Raybould G, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev 2020; 1:CD003857.</a></li><li><a class="nounderline abstract_t">Homer HA, Li TC, Cooke ID. The septate uterus: a review of management and reproductive outcome. Fertil Steril 2000; 73:1.</a></li><li><a class="nounderline abstract_t">Practice Committee of the American Society for Reproductive Medicine. Current clinical irrelevance of luteal phase deficiency: a committee opinion. Fertil Steril 2015; 103:e27.</a></li><li><a class="nounderline abstract_t">Balasch J, Fábregues F, Creus M, Vanrell JA. The usefulness of endometrial biopsy for luteal phase evaluation in infertility. Hum Reprod 1992; 7:973.</a></li><li><a class="nounderline abstract_t">Coutifaris C, Myers ER, Guzick DS, et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril 2004; 82:1264.</a></li><li><a class="nounderline abstract_t">Casadei L, Puca F, Privitera L, et al. Inherited thrombophilia in infertile women: implication in unexplained infertility. Fertil Steril 2010; 94:755.</a></li><li><a class="nounderline abstract_t">Coulam CB, Jeyendran RS. Thrombophilic gene polymorphisms are risk factors for unexplained infertility. Fertil Steril 2009; 91:1516.</a></li><li><a class="nounderline abstract_t">Steinvil A, Raz R, Berliner S, et al. Association of common thrombophilias and antiphospholipid antibodies with success rate of in vitro fertilisation. Thromb Haemost 2012; 108:1192.</a></li><li><a class="nounderline abstract_t">Kallen CB, Arici A. Immune testing in fertility practice: truth or deception? Curr Opin Obstet Gynecol 2003; 15:225.</a></li><li><a class="nounderline abstract_t">Tersigni C, Castellani R, de Waure C, et al. Celiac disease and reproductive disorders: meta-analysis of epidemiologic associations and potential pathogenic mechanisms. Hum Reprod Update 2014; 20:582.</a></li><li><a class="nounderline abstract_t">Clementini E, Palka C, Iezzi I, et al. Prevalence of chromosomal abnormalities in 2078 infertile couples referred for assisted reproductive techniques. Hum Reprod 2005; 20:437.</a></li><li><a class="nounderline abstract_t">Christensen RB, Matsumoto AM, Bremmer WJ. Idiopathic hypogonadotropic hypogonadism with anosmia (Kallmann syndrome). Endocrinologist 1992; 2:332.</a></li><li><a class="nounderline abstract_t">de Roux N, Young J, Misrahi M, et al. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med 1997; 337:1597.</a></li><li><a class="nounderline abstract_t">Layman LC, Cohen DP, Jin M, et al. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat Genet 1998; 18:14.</a></li><li><a class="nounderline abstract_t">Aittomäki K, Lucena JL, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995; 82:959.</a></li><li><a class="nounderline abstract_t">Phillip M, Arbelle JE, Segev Y, Parvari R. Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone. N Engl J Med 1998; 338:1729.</a></li><li><a class="nounderline abstract_t">Toledo SP, Brunner HG, Kraaij R, et al. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J Clin Endocrinol Metab 1996; 81:3850.</a></li><li><a class="nounderline abstract_t">Schwartz CE, Dean J, Howard-Peebles PN, et al. Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet 1994; 51:400.</a></li><li><a class="nounderline abstract_t">Achermann JC, Meeks JJ, Jameson JL. Phenotypic spectrum of mutations in DAX-1 and SF-1. Mol Cell Endocrinol 2001; 185:17.</a></li><li><a class="nounderline abstract_t">Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387:903.</a></li><li><a class="nounderline abstract_t">Clément K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392:398.</a></li><li><a class="nounderline abstract_t">de Roux N, Genin E, Carel JC, et al. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A 2003; 100:10972.</a></li><li><a class="nounderline abstract_t">Seminara SB, Messager S, Chatzidaki EE, et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003; 349:1614.</a></li><li><a class="nounderline abstract_t">Dodé C, Levilliers J, Dupont JM, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 2003; 33:463.</a></li><li><a class="nounderline abstract_t">Feng R, Sang Q, Kuang Y, et al. Mutations in TUBB8 and Human Oocyte Meiotic Arrest. N Engl J Med 2016; 374:223.</a></li></ol></div><div id="topicVersionRevision">Topic 5408 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : WHO Technical Report Series. Recent Advances in Medically Assisted Conception Number 820, 1992, pp 1-111.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24559617" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Female age-related fertility decline. Committee Opinion No. 589.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4935165" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Radiosensitivity of mammalian oocytes with particular reference to the human female.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3119654" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7650119" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A mathematical model of follicle dynamics in the human ovary.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/69066" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Relation between smoking and age of natural menopause. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7962282" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Determinants of basal follicle-stimulating hormone levels in premenopausal women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11020495" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Predictors of ovarian follicle number.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19589949" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Ovarian aging: mechanisms and clinical consequences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24559614" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Relationship between ovarian cysts and infertility: what surgery and when?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22285747" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Committee opinion: role of tubal surgery in the era of assisted reproductive technology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28865538" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31995657" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Surgical treatment of fibroids for subfertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10632403" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The septate uterus: a review of management and reproductive outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25681857" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Current clinical irrelevance of luteal phase deficiency: a committee opinion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1430139" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The usefulness of endometrial biopsy for luteal phase evaluation in infertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15533340" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Histological dating of timed endometrial biopsy tissue is not related to fertility status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19939360" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Inherited thrombophilia in infertile women: implication in unexplained infertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18930220" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Thrombophilic gene polymorphisms are risk factors for unexplained infertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23052827" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Association of common thrombophilias and antiphospholipid antibodies with success rate of in vitro fertilisation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12858110" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Immune testing in fertility practice: truth or deception?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24619876" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Celiac disease and reproductive disorders: meta-analysis of epidemiologic associations and potential pathogenic mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15567875" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Prevalence of chromosomal abnormalities in 2078 infertile couples referred for assisted reproductive techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Idiopathic hypogonadotropic hypogonadism with anosmia (Kallmann syndrome)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9371856" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9425890" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7553856" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9624193" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8923827" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7943006" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Obstetrical and gynecological complications in fragile X carriers: a multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11738790" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Phenotypic spectrum of mutations in DAX-1 and SF-1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9202122" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Congenital leptin deficiency is associated with severe early-onset obesity in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9537324" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12944565" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14573733" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The GPR54 gene as a regulator of puberty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12627230" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26789871" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Mutations in TUBB8 and Human Oocyte Meiotic Arrest.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
